Primer: Paradigm Biopharmaceuticals (PAR AU) - Aug 2026
Paradigm is a late-stage, single-asset biopharmaceutical company whose value is almost entirely dependent on the clinical and commercial success...
112 Views
š¼SK or SearchENTITY
Paradigm Biopharmaceuticals (PAR AU)
Paradigm Biopharmaceuticals (PAR AU)
22
Analysis
Health Care ā¢ Australia
Paradigm Biopharmaceuticals Limited operates as a biopharmaceutical company. The Company develops PPS drug to treat respiratory diseases such as allergic asthma, allergic rhinitis, and chronic obstructive pulmonary. Paradigm Biopharmaceuticals offers its services in Australia.
morex